Business
Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND
SOUTH SAN FRANCISCO, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five poster presentations at the 30th
About this update from Cytokinetics, Incorporated
[{"type":"text","content":"SOUTH SAN FRANCISCO, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five poster presentations at the 30th International Symposium on ALS/MND in Perth, Australia. The posters will be presented on Thursday, December 5, 2019 and Friday, December 6, 2019.\n Thursday, December 5, 2019 (All times listed below are local time in Perth) Poster Session ATheme: Clinical Trials and Trial Design Title: Responder and Subgroup Analyses for FORTITUDE-ALS, a Phase 2 Trial Study of Reldesemtiv in Patients with ALSPresentation Time: 10:30 – 11:30 AMPoster Number: CLT-21Poster Presenter: Jeremy M. Shefner, M.D., Ph.D., Lead Investigator of FORTITUDE-ALS, Professor and Chair of Neurology at Barrow Neurological Institute, and Professor and Executive Chair of Neurology at the University of Arizona, Phoenix Title: Quality of Life and Depression Measurements in FORTITUDE-ALSPresentation Time: 10:30 – 11:30 AMPoster Number: CLT-22Poster Presenter: Stacy Rudnicki, M.D., Senior Medical Director, Clinical Research, Neurology, Cytokinetics Title: Impact of ALSFRS-R progression rates on outcome measures in FORTITUDE-ALS Presentation Time: 10:30 – 11:30 AMPoster Number: CLT-23Poster Presenter: Stacy Rudnicki, M.D., Senior Medical Director, Clinical Research, Neurology, Cytokinetics Title: Utilization of Durable Medical Equipment in FORTITUDE-ALSPresentation Time: 10:30 – 11:30 AMPoster Number: CLT-20Poster Presenter: Stacy Rudnicki, M.D., Senior Medical Director, Clinical Research, Neurology, Cytokinetics Friday, December 6, 2019 Poster Session BTheme: Biomedical and Clinical Work in Progress Title: People Living with ALS and Their Caregivers’ Input into Drug Development in EuropePresentation Time: 6:00 – 7:00 PMPoster Number: WP-14Poster Presenter: Miriam Galvin, Ph.D., Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin About Cytokinetics Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and best-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically enginee...